[NICE Guidline] Caesarean section Clinical guideline [CG132]

NICE | April 2019| Caesarean section Clinical guideline [CG132]

NICE have updated their guideline: Caesarean section. This NICE guideline covers when to offer caesarean section, procedural aspects of the operation and care after caesarean section. It aims to improve the consistency and quality of care for women who are considering a caesarean section or have had a caesarean section in the past and are now pregnant again.

In April 2019 NICE withdrew a recommendation on wound closure methods and replaced it with a link to the updated NICE guideline on surgical site infections: prevention and treatment.

Full details are available from NICE 

[NICE guideline [NG125] Surgical site infections: prevention and treatment

NICE | April 2019 | Surgical site infections: prevention and treatment

This guideline covers preventing and treating surgical site infections in adults, young people and children who are having a surgical procedure involving a cut through the skin. It focuses on methods used before, during and after surgery to minimise the risk of infection.

healthcare-hospital-lamp-1250655.jpg

This guideline includes new and updated recommendations on:

It also includes recommendations on:

Full information is available from NICE 

[NICE Guideline] Delirium: prevention, diagnosis and management Clinical guideline [CG103]

NICE | March 2019 | Delirium: prevention, diagnosis and management Clinical guideline [CG103]

NICE has updated this clinical guideline, the guideline covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications.

In March 2019 NICE removed the use of olanzapine for the treatment of delirium in people who are distressed or considered a risk to themselves or others.

Full details from NICE 

NICE publishes a summary of its guidance and other safety advice on valproate

NICE | March 2019 | NICE publishes a summary of its guidance and other safety advice on valproate

NICE has recently published a summary for health professionals, collating all of its recommendations and safety advice on valproate.

NICE publishes a summary of its guidance and other safety advice on valproate

The NICE summary sheet on valproate brings together existing information and advice on safe prescribing from other sources (for example, MHRA safety alerts, BNF information, summary of products data and information from the Driver and Vehicle Licensing Agency) with NICE’s existing guideline recommendations, to produce easy to access, practical recommendations supported by a visual summary.

See also:

Summary sheet Valproate in children, young people and adults: summary of NICE guidance and safety advice

RCP joins UK healthcare bodies in launch of ‘pragmatic’ guidance on valproate use

[NICE Guideline Surveillance Report] Acutely ill adults in hospital: recognising and responding to deterioration Clinical guideline [CG50]

NICE | February 2019 | Acutely ill adults in hospital: recognising and responding to deterioration

2019 exceptional surveillance of sepsis: recognition, diagnosis and early management (NICE guideline NG51) and acutely ill adults in hospital: recognising and responding to deterioration (NICE guideline CG50).

Surveillance decision

  • Reason for the proposal

The NICE guidelines on sepsis and acutely ill adults in hospital will be amended to state that the early warning score NEWS2 has been endorsed by NHS England.

These changes will be addressed through editorial amendments.

Full details are available from NICE